Literature DB >> 34182791

Remdesivir-Induced Bradycardia in COVID-19: A Single Center Prospective Study.

Emilio Attena1, Stefano Albani1,2, Alberto Enrico Maraolo3, Mariano Mollica4, Annunziata De Rosa5, Raffaella Pisapia3,5, Giuseppe Fiorentino4, Roberto Parrella, Sergio Severino, Vincenzo Russo6.   

Abstract

Entities:  

Keywords:  COVID-19; bradycardia; heparin; pneumonia; pulmonary embolism; remdesivir

Year:  2021        PMID： 34182791     DOI： 10.1161/CIRCEP.121.009811

Source DB:  PubMed          Journal:  Circ Arrhythm Electrophysiol        ISSN： 1941-3084


× No keyword cloud information.
  12 in total

1.  Remdesivir-Induced Marked Sinus Bradycardia in COVID-19.

Authors:  Taimoor Ahmed; Samra Haroon Lodhi; Taha Ahmed
Journal:  Cureus       Date:  2022-07-25

2.  Bradyarrhythmia After Remdesivir Administration in SARS-CoV-2: A Review of Literature and Meta-Analysis of Observational Studies in Epidemiology.

Authors:  Safa Al-Jammali; Rana Al-Zakhari; Nicholas Sheets; Arun Mahtani; Veronika Stefanishina; Nidal Isber
Journal:  Cardiol Res       Date:  2022-05-10

3.  Remdesivir-induced bradycardia in a 26-year-old patient with COVID-19: a case report.

Authors:  Katarzyna Guziejko; Jaroslaw Talalaj; Monika Chorazy; Monika Groth; Anna Moniuszko-Malinowska
Journal:  Infection       Date:  2022-06-14       Impact factor: 7.455

4.  Pulmonary Edema in COVID-19 Treated with Furosemide and Negative Fluid Balance (NEGBAL): A Different and Promising Approach.

Authors:  Jose L Francisco Santos; Patricio Zanardi; Veronica Alo; Marcelo Rodriguez; Federico Magdaleno; Virginia De Langhe; Vanina Dos Santos; Giuliana Murialdo; Andrea Villoldo; Micaela Coria; Diego Quiros; Claudio Milicchio; Eduardo Garcia Saiz
Journal:  J Clin Med       Date:  2021-11-28       Impact factor: 4.241

5.  Remdesivir-Associated Sinus Arrest in COVID-19: A Potential Indication for Close Cardiac Monitoring.

Authors:  Grant E Gregory; Hannah M Gregory; Hamza Liaqat; Mina M Ghaly; Kristy D Johnson-Pich
Journal:  Cureus       Date:  2022-02-17

Review 6.  Characteristics of bradyarrhythmia in patients with COVID-19: Systematic scoping review.

Authors:  Todd Nagamine; Sandeep Randhawa; Yoshito Nishimura; Ricky Huang; Thiratest Leesutipornchai; Kevin Benavente; Stephanie Yoshimura; James Zhang; Chanavuth Kanitsorphan
Journal:  Pacing Clin Electrophysiol       Date:  2022-03-03       Impact factor: 1.912

7.  Clinical Characteristics and Implications of Bradycardia in COVID-19 Patients Treated with Remdesivir: A Single-Center Retrospective Cohort Study.

Authors:  Ariyon Schreiber; Justin S Bauzon; Kavita Batra; Salman Mohammed; Kevin Lee; Nazanin Houshmand; Uyen Pham; Celica Cosme; Kim Inciong; Omar Al-Taweel; Keaton Nasser; Jibran Rana; Chris Sossou; Ariel Go; Dalia Hawwass; Jimmy Diep; Chowdhury H Ahsan
Journal:  Clin Drug Investig       Date:  2022-08-17       Impact factor: 3.580

8.  Bradycardia and Heart Rate Fluctuation Are Associated with a Prolonged Intensive Care Unit Stay in Patients with Severe COVID-19.

Authors:  Pattraporn Tajarernmuang; Konlawij Trongtrakul; Warawut Chaiwong; Teerapat Nantsupawat; Athavudh Deesomchok; Panida Chanayat; Nutchanok Niyatiwatchanchai; Theerakorn Theerakittikul; Atikun Limsukon; Chaicharn Pothirat; Chalerm Liwsrisakun; Chaiwat Bumroongkit
Journal:  Medicina (Kaunas)       Date:  2022-07-19       Impact factor: 2.948

9.  Ventricular Tachycardia or Fibrillation Storm in Coronavirus Disease.

Authors:  Muhammad H Khan; Obadah Aqtash; David M Harris; Alexandru I Costea; Myron C Gerson
Journal:  Case Rep Cardiol       Date:  2022-08-18

Review 10.  Nasal Nanovaccines for SARS-CoV-2 to Address COVID-19.

Authors:  Jialu Huang; Yubo Ding; Jingwei Yao; Minghui Zhang; Yu Zhang; Zhuoyi Xie; Jianhong Zuo
Journal:  Vaccines (Basel)       Date:  2022-03-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.